Cardiac Science Corp (MM) (NASDAQ:CSCX)
Historical Stock Chart
5 Years : From Dec 2008 to Dec 2013
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors Cardiac Science
Corporation (“Cardiac Science”) or the “Company”) (Nasdaq:CSCX) relating
to the proposed acquisition by Opto Circuits Limited (“Opto”).
Under the terms of the transaction, Cardiac Science shareholders would
receive cash of $2.30 for each share of Cardiac Science stock they own.
The investigation concerns possible breaches of fiduciary duty and other
violations of state law. The transaction appears to be unfair, in part,
given that the offer represents no premium over the $2.47 a share
Cardiac Science stock traded at as recently as August 4, 2010 and an
analyst set a price target for Cardiac Science at $6.00 per share. Thus,
shareholders need additional information to know if the Board of
Directors breached their fiduciary duties by failing to adequately shop
the Company, which has resulted in Opto underpaying for the company.
If you own shares of Cardiac Science and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at firstname.lastname@example.org,
or by calling toll free 877-LEGAL-90.